(Q43963204)

28 November 2017

title

Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia (English)

1 reference

28 November 2017

1 reference

Xiang Yang Zhang

1

1 reference

28 November 2017

Dong Feng Zhou

2

1 reference

28 November 2017

Cao Lian Yuan

3

1 reference

28 November 2017

Pei Yan Zhang

4

1 reference

28 November 2017

Gui Ying Wu

5

1 reference

28 November 2017

Yu Cun Shen

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

109

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

297-302

1 reference

Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Clozapine: plasma levels and prolactin response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Prolactin levels and adverse events in patients treated with risperidone.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Effects of haloperidol treatment on prolactin response to D -fenfluramine challenge in acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Atypical antipsychotics: are some more atypical than others?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900022-7

7 January 2021

10.1016/S0165-1781(02)00022-7

Identifiers

DOI

1 reference

28 November 2017

1 reference